Lymph node assessment with 18F-FDG-PET and MRI in uterine cervical cancer

Anticancer Research

Volumn 31, Issue 11, 2011, Pages 3865-3871

  Monteil, Jacques ^a   Maubon, Antoine ^a   Leobon, Sophie ^a   Roux, Sonia ^a   Marin, Benoit ^a   Renaudie, Joel ^b   Genet, Dominique ^c   Fermeaux, Véronique ^a   Aubard, Yves ^d   Tubiana Mathieu, Nicole ^a  

^a LIMOGES UNIVERSITY HOSPITAL   (France)

^b Department of Gynaecology   (France)

^c Chenieux Clinic   (France)

^d Mother and Child Hospital ^*  (France)

Author keywords

FDG PET; Lymph node; MRI; Uterine cervical cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL;

ARTICLE; BRACHYTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; EXTERNAL BEAM RADIOTHERAPY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIODIAGNOSIS; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PELVIS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; UTERINE CERVICAL NEOPLASMS;

EID: 83055167282     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Kidd EA, Siegel BA, Dehdashti F, Rader JS, Mutch DG, Powell MA and Grigsby PW: Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis. J Clin Oncol 25:2108-2113, 2010.
2. Grigsby PW, Heydon K, Mutch DG, Kim RY and Eifel P: Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys 51: 982-987, 2001. (Pubitemid 33026428)
3. Bipat S, Glas AS, van der Velden J, Zwinderman AH, Bossuyt PM and Stoker J: Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. Gynecol Oncol 91: 59-66, 2003. (Pubitemid 37188594)
4. Sugawara Y, Eisbruch A, Kosuda S, Recker BE, Kison PV and Wahl RL: Evaluation of FDG PET in patients with cervical cancer. J Nucl Med 40: 1125-1131, 1999. (Pubitemid 29315502)
5. Rose PG, Adler LP, Rodriguez M, Faulhaber PF, Abdul-Karim FW and Miraldi F: Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. J Clin Oncol 17: 41-45, 1999. (Pubitemid 29022376)
6. Kitajima K, Murakami K, Yamasaki E, Kaji Y and Sugimura K: Accuracy of integrated FDG-PET/contrast-enhanced CT in detecting pelvic and paraaortic lymph node metastasis in patients with uterine cancer. Eur Radiol 19: 1529-1536, 2009.
7. Boughanim M, Leboulleux S, Rey A, Pham CT, Zafrani Y, Duvillard P, Lumbroso J, Haie-Meder C, Schlumberger M and Morice P: Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area. J Clin Oncol 26: 2558-2561, 2008.
8. Monteil J, Mahmoudi N, Leobon S, Roudaut PY, El Badaoui A, Verbeke S, Venat-Bouvet L, Martin J, Le Brun-Ly V, Lavau-Denes S, Maubon A, Bouillet P, Pouquet M, Vandroux JC and Tubiana-Mathieu N: Chemotherapy response evaluation in metastatic colorectal cancer with FDG PET/CT and CT scans. Anticancer Res 29: 2563-2568, 2009.
9. Melloni B, Monteil J, Vincent F, Bertin F, Gaillard S, Ducloux T, Verbeke S, Maubon A, Vandroux JC and Bonnaud F: Assessment of 18F-fluorodeoxyglucose dual-head gamma camera in asbestos lung diseases. Eur Respir J 24: 814-821, 2004. (Pubitemid 39504437)
10. Morisawa N, Koyama T and Togashi K: Metastatic lymph nodes in urogenital cancers: contribution of imaging findings. Abdom Imaging [Review] 31: 620-629, 2006. (Pubitemid 46360851)
11. Lin WC, Hung YC, Yeh LS, Kao CH, Yen RF and Shen YY: Usefulness of (18)F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings. Gynecol Oncol 89: 73-76, 2003. (Pubitemid 36403649)
12. Choi HJ, Roh JW, Seo SS, Lee S, Kim JY, Kim SK, Kang KW, Lee JS, Jeong JY and Park SY: Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study. Cancer 106: 914-922, 2006. (Pubitemid 43238460)
13. Loft A, Berthelsen AK, Roed H, Ottosen C, Lundvall L, Knudsen J, Nedergaard L, Hojgaard L and Engelholm SA: The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study. Gynecol Oncol 106: 29-34, 2007. (Pubitemid 46908743)
14. Reinhardt MJ, Ehritt-Braun C, Vogelgesang D, Ihling C, Hogerle S, Mix M, Moser E and Krause TM: Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology 218: 776-782, 2001. (Pubitemid 32172564)
15. Sironi S, Buda A, Picchio M, Perego P, Moreni R, Pellegrino A, Colombo M, Mangioni C, Messa C and Fazio F: Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. Radiology 238: 272-279, 2006. (Pubitemid 43010605)
16. Chung HH, Park NH, Kim JW, Song YS, Chung JK and Kang SB: Role of integrated PET-CT in pelvic lymph node staging of cervical cancer before radical hysterectomy. Gynecol Obstet Invest 67: 61-66, 2009.
17. 18F-FDG positron-emission-tomography in cervical carcinoma: preliminary findings]. Zentralbl Gynakol 123: 229-235, 2001.
18. Narayan K, Hicks RJ, Jobling T, Bernshaw D and McKenzie AF: A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer: potential impact on treatment. Int J Gynecol Cancer 11: 263-271, 2001. (Pubitemid 32751393)
19. 18F]-fluoro-2-deoxy-D-glucose- positron emission tomography. Cancer 104: 2484-2491, 2005.
20. Grigsby PW, Siegel BA and Dehdashti F: Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 19: 3745-3749, 2001. (Pubitemid 32844787)
21. Tsai CS, Chang TC, Lai CH, Tsai CC, Ng KK, Hsueh S, Yen TC and Hong JH: Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI/CT. Int J Radiat Oncol Biol Phys 58: 1506-1512, 2004. (Pubitemid 38438314)
22. Chung HH, Kang KW, Cho JY, Kim JW, Park NH, Song YS, Kim SH, Chung JK and Kang SB: Role of magnetic resonance imaging and positron emission tomography/computed tomography in preoperative lymph node detection of uterine cervical cancer. Am J Obstet Gynecol 203: 156 e1-5, 2010.
23. Kang S, Kim SK, Chung DC, Seo SS, Kim JY, Nam BH and Park SY: Diagnostic value of (18)F-FDG PET for evaluation of paraaortic nodal metastasis in patients with cervical carcinoma: a metaanalysis. J Nucl Med 51: 360-367, 2010.
24. 18f]fluorodeoxyglucose positron-emission tomography scan and histology of pelvic nodes in early-stage cervical cancer. Anticancer Res 30: 1029-1032, 2010.
25. 18Fluoro-2deoxy-d-glucose- positron emission tomography and locally advanced cervical cancer. Int J Gynecol Cancer 19: 8-12, 2009.
26. Leblanc E, Narducci F, Frumovitz M, Lesoin A, Castelain B, Baranzelli MC, Taieb S, Fournier C and Querleu D: Therapeutic value of pretherapeutic extraperitoneal laparoscopic staging of locally advanced cervical carcinoma. Gynecol Oncol 105: 304-311, 2007. (Pubitemid 46590320)